Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global autologous stem cell and non-stem cell based therapies market is expected to grow at a CAGR of around 11.2% during 2025-2034. This report on global autologous stem cell and non-stem cell based therapies market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global autologous stem cell and non-stem cell based therapies market by segmenting the market based on type, application, end user, and region. Also, detailed profiles of companies operating in the autologous stem cell and non-stem cell based therapies market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing cancer patients
• Increase in number of geriatric patients
Market Challenges
• High Cost
• Lack of Skilled Professionals
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Type
• Autologous Stem Cells
• Autologous Non-Stem Cells
Market by Application
• Cancer
• Neurodegenerative Disorders
• Cardiovascular Disease
• Orthopedic Diseases
• Others
Market by End User
• Hospitals
• Ambulatory Surgical Centers
• Research Facilities
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Active Data Warehousing Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Active Data Warehousing Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type
- 5.1. Introduction
- 5.2. Autologous Stem Cells
- 5.3. Autologous Non-Stem Cells
- 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application
- 6.1. Introduction
- 6.2. Cancer
- 6.3. Neurodegenerative Disorders
- 6.4. Cardiovascular Disease
- 6.5. Orthopedic Diseases
- 6.6. Others
- 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End User
- 7.1. Introduction
- 7.2. Hospitals
- 7.3. Ambulatory Surgical Centers
- 7.4. Research Facilities
- 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Region
- 8.1. Introduction
- 8.2. Europe
- 8.2.1. Germany
- 8.2.2. United Kingdom
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Netherlands
- 8.2.8. Rest of the Europe
- 8.3. North America
- 8.3.1. United States
- 8.3.2. Canada
- 8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Indonesia
- 8.4.7. Rest of the Asia Pacific
- 8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
- 8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. Turkey
- 8.6.3. Iran
- 8.6.4. United Arab Emirates
- 8.6.5. Rest of Middle East & Africa
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Company Profiles
- 12.1.1 BrainStorm Cell Limited
- 12.1.2 Caladrius Biosciences Inc.
- 12.1.3 Castle Creek Biosciences Inc.
- 12.1.4 Cytori Therapeutics Inc.
- 12.1.5 Dendreon Pharmaceuticals LLC
- 12.1.6 Gilead Sciences Inc.
- 12.1.7 Holostem Terapie Avanzate Srl
- 12.1.8 Novartis International AG
- 12.1.9 US Stem Cell Inc.
- 12.1.10 Vericel Corp.
- List of Figures
- Figure 1: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 2: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type, 2024
- Figure 3: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application, 2024
- Figure 4: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End User, 2024
- Figure 5: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Region, 2024
- Figure 6: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 7: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type (in %), 2024 & 2034
- Figure 8: Global Autologous Stem Cells Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 9: Global Autologous Stem Cells Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 10: Global Autologous Non-Stem Cells Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 11: Global Autologous Non-Stem Cells Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 12: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application (in %), 2024 & 2034
- Figure 13: Global Cancer Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 14: Global Cancer Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 15: Global Neurodegenerative Disorders Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 16: Global Neurodegenerative Disorders Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 17: Global Cardiovascular Disease Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 18: Global Cardiovascular Disease Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 19: Global Orthopedic Diseases Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 20: Global Orthopedic Diseases Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 21: Global Other Applications Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 22: Global Other Applications Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 23: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End User (in %), 2024 & 2034
- Figure 24: Global Hospitals Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 25: Global Hospitals Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 26: Global Ambulatory Surgical Centers Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 27: Global Ambulatory Surgical Centers Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 28: Global Research Facilities Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 29: Global Research Facilities Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 30: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Region (in %), 2024 & 2034
- Figure 31: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 32: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 33: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in %), 2024 & 2034
- Figure 34: Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 35: United Kingdom Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 36: France Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 37: Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 38: Spain Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 39: Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 40: Netherlands Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 41: North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 42: North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 43: North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in %), 2024 & 2034
- Figure 44: United States Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 45: Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 46: Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 47: Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 48: Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in %), 2024 & 2034
- Figure 49: China Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 50: Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 51: India Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 52: South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 53: Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 54: Indonesia Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 55: Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 56: Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 57: Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in %), 2024 & 2034
- Figure 58: Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 59: Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 60: Argentina Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 61: Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2024
- Figure 62: Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2025-2034
- Figure 63: Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in %), 2024 & 2034
- Figure 64: Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 65: Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 66: Iran Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 67: UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Market (in US$ Million), 2020-2034
- Figure 68: Market Value Chain
- List of Tables
- Table 1: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Portraiture
- Table 2: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type (in US$ Million), 2024 & 2034
- Table 3: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application (in US$ Million), 2024 & 2034
- Table 4: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End User (in US$ Million), 2024 & 2034
- Table 5: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Region (in US$ Million), 2024 & 2034
- Table 6: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in US$ Million), 2024 & 2034
- Table 7: North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in US$ Million), 2024 & 2034
- Table 8: Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in US$ Million), 2024 & 2034
- Table 9: Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in US$ Million), 2024 & 2034
- Table 10: Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Country (in US$ Million),
- 2024 & 2034
- Table 11: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook